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Introduction 
Intraluminal stents are now widely used to maintain 
the patency of stenosed or balloon-dilated arteries. 1'2 
Recently, self-expanding 3'4 or balloon-expandable 5"6 
stents have been used to secure intraluminal grafts in 
cases of abdominal aortic aneurysms; 3-7 they act 
instead of sutures to fix the grafts to the arterial wall. 
The preliminary clinical results of these interventional 
procedures are promising 5'6 and have created an 
enthusiastic following among interventional radi- 
ologists and vascular surgeons. However, the endo- 
vascular treatment of abdominal aortic aneurysms by 
insertion of a graft/stent combination is still in its 
infancy and has several imitations, both anatomical 
and technical. Many fundamental questions remain to 
be answered before it is accepted as an alternative to 
the standard treatment. 7 
However, this technique would seem to be applica- 
ble to other conditions apart from aneurysms, includ- 
ing arterial dissections and arteriovenous fistulae. 
Most arteriovenous malformations (AVMs) are man- 
aged conservatively. Those with a large arterial com- 
ponent which are symptomatic are usually treated by 
embolisation under radiological control, with a rela- 
tively favourable prognosis. 8 Congenital AVMs are 
amenable to surgery only when en-block resection of 
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all tissue involved in the fistula can be accomplished 
or when skeletonisation of the feeding artery is 
feasible. 9 
The intraluminal graft/stent insertion is another 
treatment option that must be considered in difficult 
AVMs. To our knowledge, insertion of a graft/stent 
combination has been used only once before, in a case 
of traumatic subclavian arteriovenous fistula with a 
single feeding vessel, 6 and never for congenital mal- 
formations. We present a case in which a huge, life 
threatening congenital AVM involving the aorta and 
inferior vena cava (IVC) was successfully treated with 
a polyester covered self-expandable aortic stent. 
Case Report 
A 29-year-old woman with multiple congenital AVMs 
resulting in hypertrophy of the left side of her body 
and Kasabach-Merritt syndrome (consumptive coagu- 
lopathy, low platelets and fibrinogen, high D-dimers) 
presented aged 14 with paraplegia due to intraspinal 
haemorrhage. She remained well until 3 years ago 
when she had a large retroperitoneal bleed. Computed 
tomography (CT) scan showed an aorta measuring 
28ram in diameter and three large retroperitoneal 
vascular spaces on the left, involving the psoas and 
spinal canal. Intraarterial digital subtraction angiog- 
raphy (DSA) showed a vascular space fed from the 
aorta by three short lumbar vessels; this space was 
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shown to be 7cm in diameter on CT scan and was in 
communication with the IVC and another two spaces 
which measured 4 cm each, one of which fed into the 
ovarian vein (Figs. 1 and 2). The blood flow through 
the fistula was very rapid so that the IVC filled 
immediately and visualisation of the aorta and its 
branches was poor. Examination of the abdomen 
revealed a large 20cm expansile pulsatile mass. 
Two embolisation procedures were carried out in 
1993 and 1994. In total some 20 m of wire and special 
coils were positioned in the vascular spaces. The flow 
was decreased, but these failed to effect occlusion (Fig. 
2). Furthermore, the consumptive coagulopathy dete- 
riorated and she subsequently suffered a second life 
threatening haemorrhage which exacerbated her high 
output cardiac failure. She was treated conservatively 
with blood and platelet ransfusions until stable. 
As surgical treatment would have been associated 
with unacceptable risks, one option was the placement 
of an intraluminal graft in the aorta to overlie the 
feeding vessels, so that the vascular spaces would be 
excluded from the circulation and finally thrombose. 
A self-expandingmetall ic stent covered with polyester 
(Dacron) was employed (provided by Dr Fred Keller, 
Charles Dotter Institute of Interventional Therapy 
Oregon, U.S.A.). The stent was a specially manu- 
factured Gianturco-Rosch Z-stent which was 7cm long 
and 28mm in diameter. This was attached to a 
standard woven polyester (Dacron) graft by multiple 
interrupted polypropylene sutures. This graft stent 
combination was loaded into a delivery sheath which 
was one mm thick and had an outer diameter of 28F. 
It was positioned in the infrarenal aorta using fluoros- 
copy and surface markers. Access to the sheath was 
gained via direct exposure of the left external iliac 
artery under general anaesthesia in the angiographic 
suite. Systemic hypotension was used during deploy- 
ment of the stent to reduce the possibility of distal 
migration. As soon as the stent was delivered in the 
selected place, the abdomen became non-pulsatile and 
the heart rate decreased to normal levels. Blood 
pressure was controlled throughout. Completion 
angiography showed one small AVM remaining pat- 
ent, fed by a lumbar artery originating almost at the 
level of the renal arteries (Figs. 3 and 4). 
Her immediate postoperative course was compli- 
cated by a slow persistent haemorrhage from the 
wound which responded to platelet ransfusion. The 
abdomen remained non-pulsatile, and her heart 
Fig. 1. CT-scan showing the left sided hypertrophy with right 
displacement of the vertebra and a large vascular space adjacent to 
the aorta (arrows). It  diameter was more than 6cm. The inferior 
vena cava is disproportionately dilated due to the high flow. 
Fig. 2. Intraarterial DSA showing the main vascular sp ce mbo- 
lised by wires and coils, which continues to communicate directly 
with the inferior vena cava (arrow). 
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decreased by 2 cm in diameter over the subsequent 48 
h. On review at 4 months, the AVM remains throm- 
bosed, the platelet count has returned to normal evels 
and the patient has had no further nose or mouth 
bleeds which had previously been a regular occur- 
rence. She has had no recurrence of shortness of breath 
or palpitations. 
Discussion 
The expanding field of minimally invasive endovas- 
cular therapy has now reached the point where 
percutaneous insertion of intraluminal grafts is fea- 
sible. Advances in vascular imaging, catheter delivery 
systems and arterial stenting 3-7'~°'1~ have all contrib- 
uted to this. The most common indication for this new 
treatment modal ity is the exclusion of abdominal 
aortic aneurysms from the circulation. 6 
However, several technical and pathophysiological 
problems associated with the technique have to be 
solved before it becomes an acceptable treatment 
modality. These include patient selection, the type of 
stent to be used (self-expandable or balloon-expand- 
able bearing barbs or hooks), the need for large bore 
sheaths and the risks of distal embolisation, leakage 
through the stent and malposit ioning of the stent. 
Embolisation will remain the main treatment for 
AVMs. The graft/stent combination is a useful adjunct 
to the therapeutic options, although its use may be 
limited. Furthermore, little is known of the long term 
outcome and the biological effect of such stents. The 
presence of a stented graft within medium sized 
arteries may provoke hyperplastic stenoses. 6 In spite 
Fig. 3. Plain abdominal X-Ray. The embolic material (20 m of wire) 
is clearly seen (curved arrow). The thick arrow indicates the lower 
border of the stent while the thin the upper. 
Fig. 4. Intraarterial DSA immediately post stent deployment. The 
arrows indicate the actual position of the stent (upper a d lower 
bo der). Note hat he IVC cannot be seen, in comparison to the pre- 
stent angiogram (Fig. 2). 
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of this uncertaintj6 deployment of such stents in cases 
of life threatening conditions eems to be justified. 
In this case we feel that the combined effect of 
embolisation and graft/stent insertion led to a favour- 
able outcome. The wires and coils provided a throm- 
bogenic surface which allowed the vascular spaces to 
thrombose when the main feeding vessels were 
occluded by the stent so decreasing the flow through 
the AVM. It is possible that thrombosis could have 
been achieved by deployment of the graft/stent 
combination alone, however, the AVM would still 
have been fed by the remaining lumbar artery and 
complete occlusion may not have been achieved. 
Recanalisation of the thrombosed spaces is also 
possible, but again the presence of the wire providing 
a permanent hrombogenic surface makes this less 
likely than if it were not present. Clinically the spaces 
are thrombosed, but to prove this is now difficult. CT 
scan, Duplex and MRI are unsuitable because of the 
large amount of foreign material. The only option is to 
perform further angiograph)4 but at present his is not 
clincally indicated. 
The main technical problem was gaining sufficient 
access to introduce the 28F sheath. It was impossible 
to cannulate the right femoral artery and a second 
incision had to be performed over the left external i iac 
arterj6 which unfortunately was also involved with 
AVMs. We anticipate that substantial technical refine- 
ment and miniaturisation will make the procedure 
safer and technically more simple in the future. This 
case illustrates the way in which a graft/stent can be 
used in the treatment of AVM which is refractory to 
current reatment options. 
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